CIK 0001703647
- Non-accelerated filer
- Smaller reporting company
Korro Bio, Inc.
Sign in to watch- Ticker
- KRRO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472324450
- Phone
- +1 617-468-1999
- Business address
- 60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
- Former names
- Frequency Therapeutics, Inc.
- Open-market buys, last 90 days
- $884,752
- in 1 filing
- Open-market sales, last 90 days
- $1,763,410
- in 5 filings, $1.8M under 10b5-1 plans
Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-07-06 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,384 | $0.34 | $471 | 198,666 |
| 2023-07-06 | Mitrano Richard J. VP Finance & Operations | Sale 10b5-1 | −224 | $0.35 | $78 | 31,529 |
| 2023-07-06 | Mitrano Richard J. VP Finance & Operations | Option exercise 10b5-1 | +758 | 32,287 | ||
| 2023-07-06 | Mitrano Richard J. VP Finance & Operations | Option exercise · Restricted Stock Unit 10b5-1 | −758 | 23,484 | ||
| 2023-07-06 | Lucchino David L. President and CEO | Sale | −2,773 | $0.34 | $943 | 429,739 |
| 2023-07-06 | Lucchino David L. President and CEO | Option exercise | +9,091 | 438,830 | ||
| 2023-07-06 | Lucchino David L. President and CEO | Option exercise · Restricted Stock Unit | −9,091 | 281,818 | ||
| 2023-07-06 | Loose Christopher R. Chief Scientific Officer | Option exercise 10b5-1 | +4,546 | 59,142 | ||
| 2023-07-06 | Loose Christopher R. Chief Scientific Officer | Sale 10b5-1 | −1,384 | $0.34 | $471 | 57,758 |
| 2023-07-06 | Loose Christopher R. Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −4,546 | 140,908 | ||
| 2023-07-05 | Mitrano Richard J. VP Finance & Operations | Option exercise 10b5-1 | +758 | 31,753 | ||
| 2023-07-05 | Mitrano Richard J. VP Finance & Operations | Option exercise · Restricted Stock Unit 10b5-1 | −758 | 24,242 | ||
| 2023-07-05 | Lucchino David L. President and CEO | Option exercise | +9,091 | 432,512 | ||
| 2023-07-05 | Lucchino David L. President and CEO | Option exercise · Restricted Stock Unit | −9,091 | 290,909 | ||
| 2023-07-05 | Loose Christopher R. Chief Scientific Officer | Option exercise 10b5-1 | +4,546 | 54,596 | ||
| 2023-07-05 | Loose Christopher R. Chief Scientific Officer | Option exercise · Restricted Stock Unit 10b5-1 | −4,546 | 145,454 | ||
| 2023-07-04 | Mitrano Richard J. VP Finance & Operations | Option exercise 10b5-1 | +25,000 | 55,995 | ||
| 2023-07-04 | Mitrano Richard J. VP Finance & Operations | Option exercise · Restricted Stock Unit 10b5-1 | −25,000 | 0 | ||
| 2023-07-04 | Lucchino David L. President and CEO | Option exercise 10b5-1 | +300,000 | 723,421 | ||
| 2023-07-04 | Lucchino David L. President and CEO | Option exercise · Restricted Stock Units 10b5-1 | −300,000 | 0 |
Page 15 of 23 · 441 trades